The acquisition of NMT, Nordisk Medicin & Teknik AB, a medtech agency company that markets and sells urology products, will cost ProstaLund approximately SEK 4 million. Buying NMT will complete ProstaLund’s current product portfolio and increase the corporate group’s revenues with SEK 5 mAlready a subscriber Login You have read…